Health Canada drug identification number

DIN 00786217 — (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP 900 MG; 300 MG

(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP is a liquid of Potassium Chloride / Sodium Chloride marketed by BAXTER CORPORATION. The full Potassium Chloride / Sodium Chloride monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
00786217
Brand name
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP
Strength
900 MG; 300 MG
Dosage form
LIQUID
Route
INTRAVENOUS
Manufacturer
BAXTER CORPORATION
Health Canada status
MARKETED
Drug class
Electrolyte replenisher (a parenteral solution affecting electrolyte balance)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Potassium Chloride / Sodium Chloride products

DINBrandStrengthFormManufacturerStatus
00786209 (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP 150 MG; 900 MG SOLUTION BAXTER CORPORATION MARKETED
02299100 POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE 0.9 G; 0.15 G SOLUTION ICU MEDICAL CANADA INC DORMANT
02269414 POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP 450 MG; 150 MG SOLUTION BAXTER CORPORATION MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.